Revenue segments as reported by the company.

Products

Premiums

Services

Net investment income

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Benefit costs

Operating expenses

Goodwill impairment

Store impairments

Opioid litigation charges

Loss on assets held for sale

Restructuring charge

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

CVS Health

Aetna is an American managed health care company, which sells traditional and consumer directed health care insurance plans and related services, such as medical, pharmaceutical, dental, behavioral health, long-term care, and disability plans. Aetna is a member of the Fortune 500.

Aetna

CVS Pharmacy is a subsidiary of the American retail and health care company CVS Health, headquartered in Woonsocket, Rhode Island. It was also known as, and originally named the Consumer Value Store and was founded in Lowell, Massachusetts, in 1963. The chain was owned by its original holding company Melville Corporation since its inception until its current parent company CVS Health was spun off into its own company in 1996. CVS Pharmacy is currently the largest pharmacy chain in the United States by number of locations (over 9,600 as of 2016) and total prescription revenue. As the retail pharmacy division of CVS Health, it ranks as the 7th largest U.S. corporation according to Fortune 500 in 2016. CVS Pharmacy's leading competitor Walgreens Boots Alliance ranked 37th.

CVS Pharmacy

CVS Health Corp. is a health solutions company, which engages in the provision of healthcare services. It operates through the following segments: Health Care Benefits, Health Services, Pharmacy and Consumer Wellness, and Corporate and Other. The Health Care Benefits segment operates as a health care benefits provider. The Health Services segment offers a full range of PBM solutions, delivers health care services in its medical clinics, virtually, and in the home. The Pharmacy & Consumer Wellness segment dispenses prescriptions in its retail pharmacies and through its infusion operations. The Corporate and Other Segment is involved in management and administrative expenses. The company was founded by Stanley P. Goldstein and Ralph Hoagland in 1963 and is headquartered in Woonsocket, RI.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

CVS Health exceeds Q4 expectations, eyes growth with Oak Street

CVS Health's strong financial performance in 2022, driven by revenue growth and exceeding EPS expectations, positions the company well for future growth.
The acquisition of Oak Street Health presents opportunities to expand into primary care and improve long-term earnings growth, despite challenges in maintaining retail performance.

CVS Health excels in Q1, eyes growth through acquisitions and innovation

CVS Health's strong financial performance, strategic acquisitions, and customer-centric initiatives position the company for sustained growth and competitive advantage.
While facing challenges in the evolving healthcare landscape, CVS Health's focus on innovation, affordability, and operational efficiency provides a solid foundation for future success.
By capitalizing on opportunities in growth, synergies, and healthcare services, CVS Health can navigate industry headwinds and drive long-term value creation for stakeholders.

CVS Health reports robust Q2 earnings, eyes growth opportunities

CVS Health's Q2 2023 performance reflects strong financial results and strategic acquisitions driving growth.
Despite challenges like higher costs and restructuring charges, the company remains confident in its ability to deliver outstanding performance.
Opportunities lie in expanding Medicaid contracts, biosimilar market establishment, and clinic openings for at-risk populations.
Overall, CVS Health's focus on cost optimization, digital sales growth, and patient engagement positions it well for future success.

CVS Health reports robust Q3 earnings and strategic growth plans

CVS Health's Q3 performance reflects strong financial results and strategic initiatives across its segments, positioning the company for sustainable growth.
While facing challenges like declining vaccine demand and contract losses, CVS Health is focused on leveraging opportunities in biosimilars and cost-saving solutions.
The company's commitment to operational excellence, innovation, and workforce investment underscores its strategic vision for becoming a leading health solutions provider.
With a clear focus on growth drivers and mitigating challenges, CVS Health is poised to capitalize on market opportunities and deliver value to shareholders.

CVS Health reports robust Q4 earnings, eyes Medicare margin recovery

CVS Health's Q4 2023 earnings call highlighted strong financial performance, a cautious stance on Medicare Advantage utilization, and a focus on transforming healthcare delivery. The company is committed to margin recovery, growth, and enhancing customer experience while addressing challenges in Medicare Advantage trends and cost pressures.

CVS Health faces Medicare Advantage challenges, focuses on margin improvement

CVS Health's Q1 2024 earnings call highlighted strong financial performance, challenges in the Medicare Advantage business, and a focus on improving margins. The company showcased strengths in the biosimilar market and Pharmacy & Consumer Wellness segment while addressing issues impacting Health Care Benefits and Services segments.

CVS Health's Q2 2024 performance reflects strong financial results, cost savings, and innovative initiatives in pharmacy services.
The company faces challenges in the Health Care Benefits segment but is actively addressing them through leadership changes and operational improvements.
Opportunities for growth include driving margin improvements, expanding digital reach, and educating stakeholders on the value delivery of PBMs.
Expectation of margin recovery in Medicare Advantage and double-digit EPS growth in 2025 highlight CVS Health's strategic focus on operational efficiencies and cost savings.

CVS Health reports robust Q3 earnings, focuses on growth strategies

CVS Health's Q3 2024 performance was marked by strong financial results, leadership changes, and segment-specific challenges and successes. The company is focused on leveraging opportunities in strategic initiatives and addressing areas for improvement to drive future growth.

Revenue

Cost of revenue

Gross profit

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

CVS Health (NYSE: CVS) reported third-quarterly earnings of $1.84 per share on Wednesday, which beat the analyst consensus estimate of $1.77 by 3.95%.

CVS Health Reports Q3 Earnings Beat, Raises Guidance

As the pharmacy giant CVS opens new “health hub” stores in the U. S., the company said the addition of Aetna is boosting profits almost a year after the drugstore chain bought the nation’s third-largest health plan.

CVS Profits Rise As Health Hubs Open And Aetna Deal Takes Hold

CVS Health will close 22 "underperforming" drugstores early next year in addition to the 46 stores it closed earlier this year, the company said Wednesday in a regulatory filing.

CVS to close 22 drugstores next year

CVS Health (CVS) delivered earnings and revenue surprises of 3.95% and 2.83%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?

CVS Health (CVS) Q3 Earnings and Revenues Top Estimates

CVS Health reported third-quarter earnings early Wednesday that topped Wall Street estimates. CVS stock rose to an eight-month high after the report.

CVS Health Earnings Top Wall Street Estimates; Medical Giant At 8-Month High

CVS Health Corp  posted a better-than-expected quarterly profit on Wednesday, boosted by its pharmacy benefit management unit and the Aetna health insurance business it acquired last year.

CVS tops profit estimates on Aetna strength

CVS Health reported third-quarter earnings that beat Wall Street's estimates as its Aetna insurance business helped boost the company's profit by 10%.

CVS Health third-quarter profit rises 10% on Aetna sales

Shares of CVS Health Corp. CVS, -1.06% jumped 3.8% in premarket trading Wednesday, after the drugstore and health services company reported third-quarter earnings that beat expectations and raised its full-year outlook.

CVS Health's stock surges after profit and sales beats, raised guidance

Roku

On Wednesday, we'll get earnings from Roku and CVS Health as well as labor department productivity data.

Roku, CVS Health earnings, productivity data: Three things to watch for in the markets on Wednesday

UPS Inc. said Tuesday that its commercial drone unit had made its first revenue deliveries of prescription drugs from a CVS pharmacy in North Carolina to customers' residences.

UPS Drone Unit Makes First Revenue Deliveries For CVS

CVS Health (NYSE: CVS) announces its next round of earnings this Wednesday, November 6.

Q3 Earnings Outlook For CVS Health

UPS is rolling along with its drone delivery program, working with partner CVS Pharmacy to deliver prescription drugs to customer doorsteps via its newly deployed commercial drones.

UPS and CVS deliver prescription medicine via drone to U.S. residential customers for the first time

The flights were early tests of what could become a new way of shipping everything from prescriptions to shampoo.

UPS drone delivers medicine from CVS straight to customers' homes

CARY, NC, Nov.  05, 2019  (GLOBE NEWSWIRE) --     UPS   (NYSE:UPS) subsidiary  UPS Flight Forward Inc .  (UPSFF) and  CVS Health Corp  oration (NYSE:CVS.N) subsidiary CVS Pharmacy, Inc. today announced the successful completion of the first revenue-generating drone delivery of a medical prescription from a CVS pharmacy directly to a consumer’s home. This was followed by another delivery of a medical prescription to a second customer in a nearby retirement community. Both flights occurred on Friday, Nov. 1, 2019, using the M2 drone system by UPS partner and drone systems developer Matternet.

UPS And CVS Make First Residential Drone Deliveries Of Prescription Medicines

CVS stock price has rallied since August. Should investors buy or sell CVS stock before it reports earnings on Nov.

Will CVS Health Stock Keep Climbing After Earnings?

Over the years, CVS stock has limped along.  But this could be setting up an opportunity for investors.

Is Now the Time to Buy CVS Stock?

CVS Health's (CVS) Caremark legacy business is expected to have delivered a solid third quarter, backed by the company's robust execution of its formulary and cost-containment tools.

Can Pharmacy Services Drive CVS Health's (CVS) Q3 Earnings?

The newly-incorporated Health Care Benefits business already registers top-line contributions for CVS Health (CVS).

Can All-Line Growth Boost CVS Health's (CVS) Q3 Earnings?

AutoZone

Costco

Papa John's

Retailers are making prudent investments to strengthen digital ecosystem and delivery capabilities. While these drive sales, they entail high costs.

4 Retail Stocks Likely to Outshine This Earnings Season

AbbVie

Block

The bulls have the advantage on Wall Street, so there are breakout stocks to buy into 2020. CVS, ABBV and SQ are three with bullish charts.

3 Breakout Stocks to Buy for the Rest of 2019

Coca-Cola

Written by: Craig Adeyanju | FinScreener With the lingering trade dispute between the United States and China, along with global economic growth concerns, predictions of an impending recession shouldn’t be taken lightly — even for conservative investors. It generally a good practice to ensure a balanced portfolio, with limited exposure recession susceptible stocks.

3 Top Defensive Stocks for Your Portfolio

CyrusOne

Jim Cramer said on CNBC's "Mad Money Lightning Round" he is not a fan of Grand Canyon Education Inc (NASDAQ: LOPE).

Cramer Gives His Opinion On CyrusOne, CVS And More

Johnson & Johnson

Rite Aid

Walmart

Walmart, CVS and Rite Aid have pulled some or all 22-ounce bottles of Johnson’s baby powder from shelves to avoid confusing consumers, after a minuscule amount of asbestos was found in one bottle. Johnson & Johnson recalled all 33,000 bottles from the same lot as that bottle last Friday, a day after the US Food.

Retailers pull Johnson’s baby powder after recall

Aramark

Cigna

Chipotle

Philip Morris

Spirit AeroSystems Hlds

AllianceBernstein has combined quantitative and fundamental methods in a portfolio that has beaten the market handily for 15 years.

6 Leading Stocks From Bernstein's 'Quant + Fundamental' Portfolio

CVS Health Corp and Rite Aid Corp are removing all 22-ounce bottles of Johnson & Johnson's baby powder from their stores, following the healthcare conglomerate's recall last week of some bottles due to possible asbestos contamination.

News for CVS Health Stock (CVS)